TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1% | 26.6% | -3.2% | 2.5% | 16.0% | 13.6% | -2.7% | 5.4% | 8.2% | 24.6% | -1.0% | 9.9% | 11.0% | |
| 7.4% | 6.0% | 7.1% | 6.2% | 6.0% | 6.4% | 6.3% | 6.0% | 5.6% | 5.5% | 6.0% | 5.8% | 5.7% | |
| 0.8% | 0.6% | 0.7% | 0.8% | 0.7% | 0.8% | 0.9% | 0.9% | 0.8% | 1.1% | 1.1% | 1.0% | 1.0% | |
| -3.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.9% | 7.3% | -13.0% | -0.2% | 7.3% | -5.8% | -18.0% | -8.0% | -12.5% | 4.9% | -15.5% | -4.0% | -6.4% | |
| 3.9% | 2.7% | 3.2% | 2.3% | 3.4% | 3.1% | 3.3% | 2.3% | 3.0% | 3.0% | 4.2% | 2.5% | 3.2% | |
| 4.8% | 6.8% | 3.8% | 4.3% | 6.2% | 4.8% | 5.2% | 5.7% | 3.0% | 3.5% | 5.8% | -11.9% | 0.2% | |
| -13.0% | – | – | – | 0.0% | -16.2% | -35.2% | 0.1% | -10.1% | 0.0% | -0.6% | 0.0% | -2.7% | |
| -15.0% | -12.9% | -4.0% | -23.2% | 0.0% | -15.9% | -44.8% | 0.1% | -10.1% | 0.8% | 0.3% | 0.0% | -2.3% | |
| -10.9% | 21.9% | -6.2% | -17.6% | 24.5% | -0.4% | -41.2% | 11.1% | 0.9% | 28.7% | 4.6% | -2.1% | 8.6% | |
| -3.7% | 23.9% | -6.5% | 0.1% | 12.6% | 10.5% | -6.0% | 3.1% | 5.2% | 21.6% | -5.2% | 7.4% | 7.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.